US-FDA's approval of mix and match COVID booster shots confirmation of efficacy of vaccine cocktail approach: RDIF
Oct 21, 2021
Moscow [Russia], October 21 : Following the decision by the US Food and Drug Administration allowing individuals to receive booster shots that are different from their first COVID-19 vaccine doses, the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) reiterated that the heterologous boosting approach pioneered by the Russian Sputnik V vaccine is one of the best solutions against the pandemic.